Target intelligence / Profile preview

Neuronal apoptotic pathway

Molecular classification
Enzyme (Caspases) (UniProt, 2024), Receptor (Death receptors) (UniProt, 2024), Regulatory protein (Bcl-2 family) (UniProt, 2024), Transcription factor (p53) (UniProt, 2024)
01

Overview

Neuronal apoptotic pathways are complex signaling cascades that govern programmed cell death within the central and peripheral nervous systems. These pathways are primarily divided into the intrinsic (mitochondrial) pathway, which responds to internal cellular stress such as DNA damage or oxidative stress, and the extrinsic pathway, which is activated by external death ligands binding to cell surface receptors like TNF-alpha (Yuan & Yankner, 2000). In a healthy context, these processes are vital for the precise pruning of neurons and synapses during brain development; however, their aberrant activation is a fundamental driver of neuronal loss in neurodegenerative diseases like Alzheimer's, Parkinson's, and Amyotrophic Lateral Sclerosis (Mattson, 2000). Therapeutic intervention in these pathways typically involves the use of small molecules or biologics designed to inhibit pro-apoptotic proteins, such as Caspase-3 or Bax, or to enhance the activity of anti-apoptotic factors like Bcl-2 (Bredesen et al., 2006). While targeting these pathways offers a direct route to neuroprotection, it presents significant clinical challenges, including the risk of systemic toxicity and the potential for promoting oncogenesis by preventing necessary cell death in other tissues (StatPearls, 2023).

Other names
Programmed cell death in neuronsNeuronal apoptosisIntrinsic and extrinsic apoptotic pathways in the CNS
02

Mechanism of action

Modulation of the apoptotic cascade by inhibiting pro-apoptotic enzymes (e.g., caspases), stabilizing mitochondrial membranes to prevent cytochrome c release, or blocking death receptor signaling to prevent neuronal loss (Bredesen et al., 2006).

03

Biological functions

Apoptosis (Yuan & Yankner, 2000)Cell death (Yuan & Yankner, 2000)Developmental synaptic pruning (Mattson, 2000)Cellular homeostasis (StatPearls, 2023)
04

Disease associations

Alzheimer's disease (Mattson, 2000)Parkinson's disease (Mattson, 2000)Amyotrophic lateral sclerosis (Mattson, 2000)Ischemic stroke (Bredesen et al., 2006)Traumatic brain injury (Bredesen et al., 2006)
05

Safety considerations

Potential for oncogenesis due to systemic inhibition of programmed cell death (StatPearls, 2023)Interference with normal developmental synaptic pruning (Mattson, 2000)Off-target effects in non-neuronal tissues (Bredesen et al., 2006)Blood-brain barrier permeability for therapeutic agents (PubMed, 2022)
06

Interacting drugs

Minocycline (Bredesen et al., 2006)

4 more in the full profile.

07

Biomarkers

Cleaved Caspase-3 (PubMed, 2022)Cytochrome c release (StatPearls, 2023)Neurofilament light chain (NfL) (PubMed, 2022)Annexin V binding (PubMed, 2022)TUNEL (Terminal deoxynucleotidyl transferase dUTP nick end labeling) positivity (StatPearls, 2023)

Beyond the preview

Go deeper on Neuronal apoptotic pathway.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neuronal apoptotic pathway.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call